2.00 (-%)
As of Nov 04, 2024
Source:
Immuron Ltd is a commercial and clinical-stage biopharmaceutical company with a proprietary technology platform focused on the development and commercializationof a novel class of specifically targeted polyclonal antibodies that we believe can address significant unmet medical needs.
| Country | United States |
| Headquarters | carlton south |
| Phone Number | 61 03 9824 5254 |
| Industry | manufacturing |
| CEO | Mr. Steven Lydeamore |
| Website | www.Immuron.com |